The QT Interval Is Associated With Incident Cardiovascular Events The MESA Study by Beinart, Roy et al.
J O U R N A L O F T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y V O L . 6 4 , N O . 2 0 , 2 0 1 4
ª 2 0 1 4 B Y T H E A M E R I C A N CO L L E G E O F C A R D I O L O G Y F O U N DA T I O N I S S N 0 7 3 5 - 1 0 9 7 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j a c c . 2 0 1 4 . 0 8 . 0 3 9The QT Interval Is Associated With
Incident Cardiovascular Events
The MESA StudyRoy Beinart, MD,*y Yiyi Zhang, PHD,z João A.C. Lima, MD,* David A. Bluemke, MD, PHD,x
Elsayed Z. Soliman, MD, MSC, MS,k Susan R. Heckbert, MD, PHD,{ Wendy S. Post, MD, MS,*
Eliseo Guallar, MD, DRPH,z Saman Nazarian, MD, PHD*zABSTRACTFro
Te
an
De
Me
Un
thr
au
gra
res
rel
Lis
Yo
MaBACKGROUND Prolonged heart rate–corrected QT interval on electrocardiograms (ECGs) is associated with
increased risk of myocardial infarction and cardiovascular disease (CVD)–related deaths in patients with prevalent
coronary heart disease.
OBJECTIVES This study sought to examine the prognostic association between the baseline QT interval and incident
cardiovascular events in individuals without prior known CVD.
METHODS The corrected baseline 12-lead ECG QT interval duration (QTcorr) was determined by adjustment for age,
sex, race/ethnicity, and RR interval duration in 6,273 participants in MESA (Multi-Ethnic Study of Atherosclerosis).
Cox proportional hazards models adjusting for demographic and clinical risk factors were used to examine the association
of baseline QTcorr with incident cardiovascular events.
RESULTS The mean age at enrollment was 61.7  10 years, and 53.4% of participants were women. Cardiovascular
events occurred in 291 participants over a mean follow-up of 8.0  1.7 years. Each 10-ms increase in the baseline QTcorr
was associated with incident heart failure (hazard ratio [HR]: 1.25; 95% CI: 1.14 to 1.37), CVD events (HR: 1.12; 95% CI:
1.05 to 1.20), and stroke (HR: 1.19; 95% CI: 1.07 to 1.32) after adjustment for CVD risk factors and potential confounders.
There was no evidence of interaction with sex or ethnicity.
CONCLUSIONS The QT interval was associated with incident cardiovascular events in middle-aged and older adults
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ABBR EV I A T I ON S
AND ACRONYMS
CHD = coronary heart disease
CVD = cardiovascular disease
ECG = electrocardiogram
HF = heart failure
MI = myocardial infarction
PVD = peripheral vascular
disease
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2112interval in healthy individuals and are associ-
ated with the development of atherosclerosis
(12–14) and may therefore be mediators of
any association between the QT interval
and incident cardiovascular events. We
sought to examine the association between
baseline QT interval and incident cardiovas-
cular events in MESA (Multi-Ethnic Study of
Atherosclerosis).
METHODSSTUDY PARTICIPANTS. Inclusion criteria and methods
of the MESA study were previously described (15). In
brief, between July 2000 and August 2002, 6,814 in-
dividuals aged 45 to 84 years and free of clinically
apparent cardiovascular disease (CVD) were recruited
from 6 U.S. areas: Baltimore City and Baltimore
County, Maryland; Chicago, Illinois; Forsyth County,
North Carolina; Los Angeles County, California;
northern Manhattan and the Bronx, New York; and
St. Paul, Minnesota. A full list of participating MESA
investigators and institutions can be found at the
MESA study website (16).SEE PAGE 2120We excluded participants who were taking antiar-
rhythmic medications or medications that might
prolong the QT interval (n ¼ 205), and participants
with QRS duration $120 ms (n ¼ 336). The ﬁnal sam-
ple size was 6,273.
The study complies with the Declaration of Hel-
sinki, and the institutional review boards at all
participating centers approved the study. All partici-
pants gave written informed consent.
RISK FACTOR MEASURES. Standardized question-
naires were used to obtain information about
self-reported race/ethnicity, smoking history, and
medication use for high blood pressure, high cholesterol
levels, and diabetes. Participant height and weight were
measured, and body mass index (kg/m2) was calculated.
Resting blood pressure was measured 3 times with par-
ticipants in the seated position with an automated
oscillometric sphygmomanometer (Critikon, GE Health-
care, Waukesha, Wisconsin). The average of the last 2
measurements was used for analysis. Total cholesterol,
high-density lipoprotein (HDL) cholesterol, and glucose
levels weremeasured fromblood samples obtained after
a 12-h fast. Low-density lipoprotein (LDL) cholesterol
was calculated with the Friedewald equation (17). Dia-
beteswas deﬁned as fasting glucose$126mg/dl or use of
hypoglycemic medications.
ELECTROCARDIOGRAM ANALYSIS OF QT INTERVAL
DURATION. Standard 12-lead electrocardiograms(ECGs) were digitally acquired using a MAC 1200
electrocardiograph (GE Healthcare, Milwaukee, Wis-
consin) at 10 mm/mV calibration and speed of 25 mm/
s. ECG reading was performed centrally at the
Epidemiological Cardiology Research Center (EPI-
CARE), Wake Forest School of Medicine (Winston
Salem, North Carolina). All ECGs were initially
inspected visually for technical errors and inadequate
quality and then automatically processed with the
Marquette 12-SL program 2001 version (GE Health-
care). A global single measure of QT interval was
deﬁned as the time duration between the earliest
QRS onset to the latest T-wave offset (end) in the 12
ECG leads. We corrected the QT interval according to
the American Heart Association, American College of
Cardiology, and Heart Rhythm Society recommen-
dations for the standardization and interpretation of
the ECG using a linear regression function for
adjustment for covariates (method fully described in
the Statistical Methods section) (18).
ADJUDICATION OF EVENTS. The follow-up was 8.0
 1.7 years. In addition to 4 follow-up MESA study
examinations, participants were contacted by tele-
phone every 12 months regarding interim hospital
admissions, cardiovascular outpatient diagnoses, and
deaths. Self-reported diagnoses were conﬁrmed by
review of death certiﬁcates and medical records for
hospitalizations and outpatient cardiovascular di-
agnoses. A detailed description of events and the
process of adjudication can be found at the MESA
website (16). Two physicians from the MESA study
events committee independently reviewed all medi-
cal records for endpoint classiﬁcation using pre-
speciﬁed criteria. An incident cardiovascular event
was deﬁned as a composite of adjudicated myocardial
infarction (MI), resuscitated cardiac arrest, coronary
heart disease–related death, stroke, or stroke-related
death. The speciﬁc incidences of stroke, MI, periph-
eral vascular disease (PVD), and heart failure (HF)
were also determined.
STATISTICAL METHODS. We used a linear regression
method to adjust the QT interval for age, ethnicity,
sex, and the RR interval using model residuals
(19). Speciﬁcally, we set up a linear regression model
with QT interval as the dependent variable and age
(continuous), ethnicity (white, African American,
Chinese American, and Hispanic), sex (female or
male), and RR interval as independent variables. The
RR interval was analyzed using restricted quadratic
splines with knots at the 5th, 50th, and 95th percen-
tiles to allow a more ﬂexible and nonlinear relation-
ship between the QT and RR intervals. Model
residuals represent the component of QT interval
duration that is not explained by the independent
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2113variables. Because the average of the residuals is 0,
we rescaled the residuals by adding the mean QT in-
terval of the overall study population to calculate the
ﬁnal corrected QT interval (QTcorr). Sensitivity ana-
lyses were also performed with the Bazett heart rate–
corrected QT interval (QTb) (20) and the Framingham
QT correction formula (QTfr) (21).
Baseline characteristics were compared according
to the QTcorr distribution (categorized at <5th, 5th to
<50th, 50th to <95th, and 95th and above percentiles)
and by clinical thresholds for short QTb (#390 ms)
or QTb prolongation ($460 ms) (18), using analysis
of variance or Student t test for continuous variables
and chi-square tests for categorical variables.
Kaplan–Meier survival curves were plotted after
stratiﬁcation of participants by QTcorr percentiles and
compared by means of the log-rank test. Cox pro-
portional hazards models were used to evaluate the
association between baseline QTcorr and incident
cardiovascular events. The following models were
used: model 1, unadjusted; model 2, adjusted for ageTABLE 1 Baseline Characteristics for All Patients and After Stratiﬁca
Total
QTcorr<5th
(300–383 ms)
Age, yrs 61.7  10.14 61.8  10.8
Female 53.4 42.9
Race
White 38.3 32.1
African American 27.5 34.5
Chinese American 12.0 11.8
Hispanic 22.2 21.6
Hypertension 43.8 32.4
Antihypertensive medications 36.0 32.4
Systolic blood pressure, mm Hg 126.3  21.45 122.4  21.17
Heart rate, beats/min 63.1  9.59 59.4  9.93
Diabetes 11.1 10.5
Family history of heart disease 42.6 40.9
Current smoking 13.1 12.2
QRS duration, ms 91.4  9.66 88.4  9.54
QT duration, ms 410.7  30.25 383.3  24.55
QTb duration, ms 417.2  20.61 377.5  13.95
QTcorr duration, ms 410.7  17.79 374.1  9.38
QTfr duration, ms 414.8  18.9 377.4  11.2
Height, cm 166.2  10.04 166.7  10.13
Weight, lbs 172.8  38.16 163.8  35.16
Body mass index, kg/m2 28.3  5.47 26.63  4.75
Low-density lipoprotein
cholesterol, mg/dl
117.6  31.43 115.23  33.05
High-density lipoprotein
cholesterol, mg/dl
51.1  14.81 52.4  16.38
Aspirin 31.0 31.1
Statins 14.4 15.2
Education (graduate) 17.8 21.3
Values are mean  SD or %.
QTb ¼ QT interval corrected using Bazett formula; QTcorr ¼ QT interval corrected for(continuous), ethnicity (white, African American,
Chinese American, and Hispanic), and sex (female or
male); and model 3, further adjusted for antihyper-
tensive medication use (yes or no); systolic blood
pressure (continuous); cigarette smoking (never,
former, current); diabetes (yes or no); family history
of ischemic heart disease (yes or no); LDL (contin-
uous); HDL (continuous); QRS duration (continuous);
aspirin use (yes or no); statin use (yes or no); body
mass index (continuous); and education (<12 years,
completed high school to bachelor’s degree, graduate
education). Models including magnetic resonance
imaging (MRI)–derived left ventricular mass (antihy-
pertensive medication use and systolic blood pres-
sure omitted due to strong collinearity) were used in
the subset of participants with MRI data to examine
a potential mediating effect by left ventricular mass
for the association of QTcorr with cardiovascular out-
comes. For detailed analyses of the dose-response
relationship of the QTcorr with incident cardiovas-
cular events, we modeled QTcorr with restrictedtion by QTcorr Percentiles
QTcorr 5th to <50th
(384–409 ms)
QTcorr $50th to <95th
(410–440 ms)
QTcorr $95th
(441–503 ms) p Value
61.7  10.2 61.8  10.0 61.3  9.9 0.877
56.1 52.0 52.7 <0.001
0.241
39.0 38.5 36.2
26.5 27.3 30.0
12.0 12.2 10.8
22.5 22.0 23.0
38.5 47.3 56.5 <0.001
31.7 38.1 46.5 <0.001
123.8  20.40 127.9  21.43 132.1  23.91 <0.001
63.7  9.19 62.7  9.58 63.6  10.62 <0.001
10.5 10.6 15.5 0.007
43.2 42.4 41.7 0.811
12.4 12.5 18.7 0.001
90.1  9.49 92.7  9.43 92.9  10.25 <0.001
397.8  23.87 422.1  26.53 429.2  38.07 <0.001
406.5  11.33 427.5  13.24 437.2  27.35 <0.001
399.6  6.89 421.3  8.08 451.2  10.93 <0.001
403.9  9.1 425.3  10.4 433.9  25.7 <0.001
165.9  10.0 166.7  10.0 165.2  10.31 <0.001
169.9  37.31 176.0  38.14 176.2  41.28 <0.001
27.9  5.37 28.7  5.43 29.2  6.07 <0.001
117.8  31.28 117.7  31.26 116.9  31.96 0.532
51.4  14.96 50.5  14.46 51.1  14.79 0.054
30.9 31.2 30.0 0.932
14.8 14.1 14.1 0.866
18.5 17.7 13.5 <0.001
RR interval, race, age and sex; QTfr ¼ QT interval corrected using the Framingham formula.
TABLE 2 Association of Baseline QTcorr Interval With Incident CVD Events
Event
Model 1* Model 2† Model 3‡
Number of
Events/Number
at Risk§
Hazard
Ratio
(per 10 ms) 95% CI p Value
Number of
Events/Number
at Risk§
Hazard
Ratio
(per 10 ms) 95% CI p Value
Number of
Events/Number
at Risk§
Hazard
Ratio
(per 10 ms) 95% CI p Value
Stroke 109/5,913 1.22 1.11–1.35 <0.001 109/5,913 1.21 1.10–1.34 <0.001 102/5,441 1.19 1.07–1.32 0.001
MI 145/5,913 1.11 1.01–1.21 0.022 145/5,913 1.10 1.01–1.20 0.031 129/5,441 1.10 0.99–1.21 0.055
HF 146/5,913 1.30 1.19–1.41 <0.001 146/5,913 1.29 1.19–1.39 <0.001 128/5,441 1.25 1.14–1.37 <0.001
PVD 63/5,913 1.19 1.04–1.35 0.01 63/5,913 1.18 1.04–1.34 0.012 52/5,441 1.16 0.99–1.35 0.054
CHD 187/5,913 1.08 1.00–1.17 0.044 187/5,913 1.08 1.00–1.16 0.064 167/5,441 1.08 1.00–1.18 0.065
CVDk 291/5,913 1.13 1.06–1.20 <0.001 291/5,913 1.12 1.06–1.20 <0.001 264/5,441 1.12 1.05–1.20 0.001
*Model 1 was unadjusted. †Model 2 was adjusted for age, ethnicity, and sex. ‡Model 3 was adjusted for model 2 plus traditional risk factors (antihypertensive medication use, systolic blood pressure, current
smoking, diabetes, family history of ischemic heart disease, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol) and QRS duration, aspirin use, statin use, body mass index, and
education. §The number at risk varies for each model, depending upon participant follow-up and missing data. kCVD includes MI, resuscitated cardiac arrest, coronary heart disease death, stroke, and stroke
death.
CHD ¼ coronary heart disease; CVD ¼ cardiovascular disease; HF ¼ heart failure; MI ¼ myocardial infarction; PVD ¼ peripheral vascular disease; other abbreviation as in Table 1.
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2114quadratic splines with knots at the 1st, 10th, and
99th percentiles of the QTcorr distribution to provide a
description of the dose-response relationship. In
spline analyses, we used the 50th percentile of the
QTcorr distribution as the reference value (median).
Finally, we examined the interaction of QTcorr with
ethnicity and sex in its association with outcome us-
ing multiplicative interaction terms as well as using
stratiﬁed analyses by sex and ethnicity. Comparisons
of C statistics between Framingham Heart Study
(FHS) risk scores (22–24) and FHS risk scores modiﬁed
by the addition of 1 point for QTcorr $95th percentile
(440.3 ms) for their association with incident CVD,
HF, and stroke were performed. A 2-tailed p
value <0.05 was considered statistically signiﬁcant.
Statistical analyses were performed using STATA
statistical software version 12.0 (STATA Corp., LP,
College Station, Texas).
RESULTS
The average age of study participants was 61.7  10.1
years, and 53.4% of study participants were female.
The average QTcorr, QTb, and QTfr were 410.7  27.8,
417.2  20.6, and 414.8  18.9, respectively. Table 1
summarizes the baseline characteristics by QTcorr
distribution (stratiﬁed at <5th, 5th to <50th, 50th to
<95th, and 95th and above percentiles). A summary of
baseline characteristics by clinical thresholds for short
QTb at #390 ms, or QTb prolongation at $460 ms can
be found in Online Table 1.
Table 2 presents the unadjusted and adjusted as-
sociations of baseline QTcorr with incident CVD events
over the follow-up period. In fully adjusted models,
each 10-ms increase in the baseline QTcorr was posi-
tively associated with incident HF (hazard ratio [HR]:
1.25; 95% CI: 1.14 to 1.37; p < 0.001), CVD (HR: 1.12;95% CI: 1.05 to 1.20; p < 0.001), and stroke (HR: 1.19;
95% CI: 1.07 to 1.32; p < 0.001). Positive trends for
association were also noted between baseline QTcorr
and MI (HR: 1.10; 95% CI: 0.99 to 1.21; p ¼ 0.055), PVD
(HR: 1.16; 95% CI: 0.99 to 1.35; p ¼ 0.054), and coro-
nary heart disease (CHD; HR: 1.08; 95% CI: 1.00 to
1.18; p ¼ 0.065). Kaplan-Meier analyses revealed
that participants with QTcorr intervals in the highest
5th percentile had increased risks of HF, CVD, and
stroke (Online Figures 1 to 3). Consistent results
were observed with the spline regression models, in
which the risk of HF, CVD, and stroke events pro-
gressively increased with increasing QTcorr intervals
(Figures 1 to 3).
In sensitivity analyses, each 10-ms increase in the
QTb was also positively associated with incident HF
(HR: 1.27; 95% CI: 1.18 to 1.38; p < 0.001), CVD (HR:
1.15; 95% CI: 1.08 to 1.22; p < 0.001), and stroke (HR:
1.20; 95% CI: 1.10 to 1.33; p < 0.001) in fully adjusted
models. Similarly, each 10-ms increase in the QTfr was
also positively associated with incident HF (HR: 1.23;
95% CI: 1.12 to 1.34; p < 0.001), CVD (HR: 1.11; 95% CI:
1.04 to 1.19; p ¼ 0.002), and stroke (HR: 1.17; 95% CI:
1.06 to 1.30; p ¼ 0.003) in fully adjusted models.
The baseline QTcorr had a weak positive associa-
tion with left ventricular mass (Spearman rho 0.072;
p < 0.001). Despite reduced power, the baseline
QTcorr interval remained associated with incident HF
(HR: 1.25; 95% CI: 1.00 to 1.55; p ¼ 0.051) and CVD
(HR: 1.20; 95% CI: 1.04 to 1.37; p ¼ 0.010) after
adjustment for left ventricular mass and other po-
tential confounders in the subset of participants
with MRI data (Online Table 2). After adjustment for
left ventricular mass in this small subset of partici-
pants, positive trends for association were also
noted between baseline QTcorr and stroke (HR: 1.21;
95% CI: 0.99 to 1.48; p ¼ 0.061), MI (HR: 1.17; 95%
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CENTRAL ILLUSTRATION Sympathetic and Parasympathetic Stimuli, the QT
Interval, and CVD Events
There is a complex interaction between the central nervous system sympathetic and
parasympathetic stimuli and cardiac conduction intervals. By increasing the heart rate,
sympathetic stimulation (green arrows) can secondarily decrease the QT interval. In
contrast, by decreasing the heart rate, parasympathetic stimulation can increase the QT
interval (orange arrows). Autonomic stimuli also exert direct effects upon the QT interval.
Increased catecholamine levels typically result in QT interval prolongation in healthy
individuals (light blue arrow). Additionally, high sympathetic tone is associated with the
development of atherosclerosis with potential secondary effects upon cardiac repolariza-
tion and the QT interval (purple arrows). Left ventricular mass is also positively associated
with high sympathetic tone and the QT interval (purple arrows). In this study, we observed
positive associations between baseline-corrected QT intervals and risks of incident stroke,
heart failure, and cardiovascular disease (CVD) events in a cohort of middle-aged partici-
pants free of CVD at baseline. Prolongation of the QT interval as a surrogate of elevated
sympathetic tone and autonomic imbalance may explain its association with cardiovascular
events. However, the QT interval may be associated with other factors, which may mediate
its association with cardiovascular events. The arrows are provided to note associations and
do not imply causality. HR ¼ hazard ratio; LVH ¼ left ventricular hypertrophy.
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2115CI: 0.98 to 1.40; p ¼ 0.087), PVD (HR: 1.23; 95% CI:
0.95 to 1.59; p ¼ 0.114), and CHD (HR: 1.17; 95% CI:
0.98 to 1.40; p ¼ 0.087).
C statistics for FHS risk scores modiﬁed with QTcorr
were higher than FHS risk scores for their association
with HF (0.735 vs. 0.724; p < 0.001), CVD (0.732 vs.
0.730; p ¼ 0.119). and stroke (0.712 vs. 0.708; p ¼
0.024).
There was no evidence of multiplicative interac-
tion with sex in the association of QTcorr with HF (HR
for interaction: 0.97; 95% CI: 0.82 to 1.15; p ¼ 0.725),
CVD (HR for interaction: 1.07; 95% CI: 0.93 to 1.21;
p ¼ 0.342), or stroke (HR for interaction: 1.09; 95% CI:
0.89 to 1.33; p ¼ 0.414). There was also no evidence of
multiplicative interaction with ethnicity in the asso-
ciation of QTcorr with HF (HR for interaction: 1.00;
95% CI: 0.99 to 1.01; p ¼ 0.834), CVD (HR for inter-
action: 1.00; 95% CI: 0.99 to 1.00; p ¼ 0.388), or stroke
(HR for interaction: 0.99; 95% CI: 0.99 to 1.01;
p ¼ 0.934). When stratiﬁed by sex and ethnicity, the
association between QTcorr and HF, CVD, and stroke
was similar among the subgroups (Figure 4).
DISCUSSION
In this study, we reported an independent positive
association between the baseline QTcorr interval and
cardiac and vascular events in middle-aged partici-
pants without prior CVD. Importantly, the association
was not limited to a speciﬁc sex or ethnicity.
Individuals with prolonged ventricular repolariza-
tion, reﬂected on the surface ECG by prolongation of
the QT interval, are predisposed to ventricular ﬁbril-
lation and sudden death. Such an association is most
evident in the setting of genetic abnormalities of
potassium and sodium channels within cell mem-
branes (25), as well as with comorbidities such as se-
vere electrolyte imbalance, central nervous system
injury, and MI (26,27). Acquired prolongation of the
QTcorr interval due to antiarrhythmic, antibiotic,
antihistaminic, or psychotropic drugs is also associ-
ated with ventricular arrhythmia and sudden death
when the QT interval exceeds 500 ms (28). In addi-
tion, several studies of participants with and with-
out prior CVD have found a positive association
between the baseline QT interval and incident cardio-
vascular mortality (8,10,19,29–31) and cardiovascular
morbidity, including a composite of atherosclerotic
disease, angina, and cardiomyopathy in a general
population sample (32) and coronary events in par-
ticipants with hypertension (5). However, the results
have been inconsistent, and negative studies of the
association between the baseline QT interval and
cardiovascular mortality (33) and coronary events(34) have also been published. A systematic review
of 7 large prospective cohort studies reported that
prolongation of the QT interval in patients with
established CVD was associated with increased risk
for total mortality, cardiovascular mortality, and
sudden death; however, among individuals without
baseline CVD, the QT interval was not associated
with these outcomes (11). In contrast, another meta-
analysis of 6 studies, with participants free of CVD
at baseline, found a positive association between
the QT interval and mortality (35).
Recently, Soliman et al. (7) reported a strong as-
sociation between the QT interval and incident stroke
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FIGURE 1 HRs for HF as a Function of the QT Interval
The blue line indicates multivariable-adjusted hazard ratios (HRs)
for heart failure (HF) as a function of corrected QT interval
(QTcorr) using restricted quadratic splines. The dashed lines
delineate the upper and lower 95% CI. The horizontal red line
indicates an HR of 1.00. The model was adjusted for age,
ethnicity, sex, antihypertensive medication use, systolic blood
pressure, cigarette smoking, diabetes, family history of ischemic
heart disease, low-density lipoprotein cholesterol, high-density
lipoprotein cholesterol, QRS duration, aspirin use, statin use,
body mass index, and education.
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FIGURE 2 HRs for CVD as a Function of the QT Interval
The blue line indicates multivariable-adjusted HRs for cardio-
vascular disease (CVD) endpoints as a function of QTcorr using
restricted quadratic splines. The dashed lines delineate the upper
and lower 95% CI. The horizontal red line indicates an HR of
1.00. Adjustment factors and other abbreviations in Figure 1.
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FIGURE 3 HRs for Stroke as a Function of the QT Interval
The blue line indicates multivariable-adjusted HRs for stroke as
a function of QTcorr using restricted quadratic splines. The dashed
lines delineate the upper and lower 95% CI. The horizontal red
line indicates an HR of 1.00. Adjustment factors and other
abbreviations as in Figure 1.
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for Geographic and Racial Differences in Stroke)
study. The results of the REGARDS study are in full
agreement with our ﬁndings. Our study differs from
the REGARDS study in that the baseline prevalence of
CVD in the REGARDS study was 17% among all par-
ticipants and 43% among those with prolonged QT.
Additionally, the REGARDS study was designed to
investigate the causes of regional and racial dis-
parities in stroke mortality, oversampling African
Americans and residents of the southeastern region of
the United States.
Several studies support an association between the
QT interval and cardiovascular events in healthy in-
dividuals. Dekker et al. (6) reported an association
between prolonged QTb (>420 ms) and the combined
endpoint of MI and CHD death compared with men
with QTb <385 ms in the Zutphen study cohort that
included 851 middle-aged men without previous MI.
In another study, Dekker et al. (9) noted an associa-
tion between QTcorr and CHD, CVD mortality, and
total mortality in the ARIC (Atherosclerosis Risk in
Communities) cohort, which included middle-aged
men and women without prior MI or coronary revas-
cularization. In contrast to our results, the risk in the
ARIC study was attenuated by ethnicity and was
higher in African Americans. Our study builds uponprior reports in healthy individuals by the use of the
regression-derived QTcorr variable with simultaneous
adjustment for age, ethnicity, sex, and heart rate and
by exclusion of participants with QRS $120 ms and
those on QT-prolonging medications.
The QT interval varies as a function of sympathetic
and parasympathetic tone (Central Illustration). In-
creased catecholamine levels induce QT interval
prolongation in healthy individuals (12–14). Addi-
tionally, high sympathetic tone is associated with the
Subgroup
Sex
Race/ethnicity
Overall
Men
0.414
1.24 (1.07, 1.43) 1.26 (1.11, 1.43) 1.16 (1.06, 1.26)
1.09 (0.98, 1.21)
1.10 (0.98, 1.23)
1.19 (1.05, 1.35)
1.03 (0.81, 1.33)
1.10 (0.95, 1.27)
1.12 (1.05, 1.20)
1.24 (1.09, 1.41)
1.19 (1.02, 1.39)
1.38 (1.18, 1.61)
1.27 (0.95, 1.69)
1.00 (0.80, 1.26)
1.25 (1.14, 1.37)
1.13 (0.98, 1.31)
1.18 (0.98, 1.43)
1.32 (1.11, 1.57)
0.54 (0.21, 1.39)
1.15 (0.93, 1.43)
1.19 (1.07, 1.32)
0.5 1.0 2.0 0.5 1.0 2.0 0.5 1.0 2.0
0.381
0.725
0.802
0.342
0.461
Women
Caucasian
African American
Chinese American
Hispanic
HR (95% CI) HR (95% CI)P-interaction
Stroke CHF CVD
P-interaction HR (95% CI) P-interaction
FIGURE 4 Forest Plot of HRs for HF, CVD, and Stroke After Stratiﬁcation by Sex and Ethnicity
The forest plot summarizes multivariable-adjusted HRs for HF, CVD, and stroke. Models were adjusted for age, ethnicity (if not stratiﬁed by ethnicity), sex (if not
stratiﬁed by sex), antihypertensive medication use, systolic blood pressure, cigarette smoking, diabetes, family history of ischemic heart disease, low-density lipoprotein
cholesterol, high-density lipoprotein cholesterol, QRS duration, aspirin use, statin use, body mass index, and education. There were no signiﬁcant differences among the
subgroups and no evidence for interaction. CHF ¼ congestive heart failure; other abbreviations as in Figures 1 and 2.
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2117development of atherosclerosis (12–14). More than 3
decades ago, Pauletto et al. (36) proposed several
mechanisms that may mediate the association of
high sympathetic tone with atherosclerosis. First,
elevated arterial pressure in the setting of high
sympathetic tone may lead to arteriolar remodeling
and alteration of ﬂow with upstream impact on the
large arteries. Secondly, epinephrine and norepi-
nephrine appear to exert direct atherogenic effects,
regardless of arterial pressure (37–41). Thirdly, the
atherogenic effects of catecholamines may be medi-
ated through platelet activation and subsequent
platelet-derived growth factor up-regulation or
platelet deposition at the arterial intima (42). Thus,
prolongation of the QT interval as a surrogate of
elevated sympathetic tone may explain its associa-
tion with cardiovascular events. The association
between QTcorr and incident HF may also be
partially mediated by an association of QTcorr and
left ventricular mass. However, despite the reduced
sample size in the cohort of MESA participants with
MRI data, the association of QTcorr with incident HF
was preserved after adjustment for left ventricular
mass. Nevertheless, QT prolongation may be asso-
ciated with other factors, which may mediate its
association with cardiovascular events. Our study
did not investigate the mechanism, and the results
simply point to an association. Finally, the associ-
ation of QTcorr with incident cardiovascular events
does not imply that the QTcorr should be used asan index for risk stratiﬁcation in the clinical setting.
Nevertheless, the C statistics for FHS risk scores
modiﬁed with the QTcorr were higher than those for
FHS risk scores for identiﬁcation of cardiovascular
events.
STUDY LIMITATIONS. We examined the association
of only a single QT interval measurement at baseline
with incident HF, CVD, and stroke events. Also, our
ﬁndings represent a selected population enrolled
from 6 different U.S. areas and may not be general-
izable to all populations. However, the inclusion of 4
different ethnicities in the MESA cohort is a signiﬁ-
cant strength that improves the applicability of the
data to various patient groups.
CONCLUSIONS
This analysis demonstrated positive associations be-
tween baseline-corrected QT intervals and risks of
incident stroke, HF, and CVD events in a cohort of
middle-aged participants free of CVD at baseline.
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PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE:
Prolongation of the corrected QT interval on the
electrocardiogram is associated with an elevated risk of
arrhythmic and sudden death, as well as incident stroke,
heart failure, and ischemic cardiovascular events in
patients with and without ischemic heart disease,
including otherwise healthy individuals, regardless of sex
or ethnicity.
TRANSLATIONAL OUTLOOK: Future studies should
evaluate the discriminative value of adding the QT
interval to existing risk assessment tools.
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